Published in TB and Outbreaks Week, October 7th, 2003
"Animal studies show that viral antibodies harvested from individuals previously exposed to the virus may be an effective therapy for speeding recovery and preventing neurological complications and death in patients infected with the virus," said Dr. Richard Whitley, UAB professor of pediatrics with the department of pediatric infectious diseases.
Funding for the study, provided by the National Institute of Allergy and Infectious Diseases (NIAID), is part of a 7-year, $42 million grant awarded to UAB...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week